Report of the Society for Vascular Surgery and the American Venous Forum on the July 20, 2016 meeting of the Medicare Evidence Development and Coverage Advisory Committee panel on lower extremity chronic venous disease

Peter Gloviczki, Michael Dalsing, Peter Henke, Brajesh K. Lal, Thomas F. O'Donnell, Cynthia K. Shortell, Ying Huang, Jovan Markovic, Thomas W. Wakefield

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

On July 20, 2016, a Medicare Evidence Development and Coverage Advisory Committee panel assessed the benefits and risks of currently used lower extremity chronic venous disease (CVD) treatments and their effects on health outcome of the American adult population. The main purpose of the meeting was to advise the Centers for Medicare & Medicaid Services on coverage determination for interventions used for treatment of CVD. A systematic review of the Agency for Healthcare Research and Quality was presented, followed by lectures of invited experts and a public hearing of representatives of professional societies and the industry. After discussing critical issues, the panel voted for key questions. This report summarizes the presented evidence to support recommendations of the Society for Vascular Surgery/American Venous Forum coalition and the presentations on selected discussion topics. These included important venous disease evidence gaps that have not been sufficiently addressed, venous disease treatment disparities and how they may affect the health outcomes of Medicare beneficiaries, and mechanisms that might be supported by the Centers for Medicare & Medicaid Services to improve the evidence base to optimize the care of patients with lower extremity CVD.[Table presented]

Original languageEnglish (US)
Pages (from-to)378-398
Number of pages21
JournalJournal of Vascular Surgery: Venous and Lymphatic Disorders
Volume5
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Advisory Committees
Medicare
Lower Extremity
Chronic Disease
Medicaid
Health Services Research
Health
Hearing
Patient Care
Industry
Therapeutics
Population

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Report of the Society for Vascular Surgery and the American Venous Forum on the July 20, 2016 meeting of the Medicare Evidence Development and Coverage Advisory Committee panel on lower extremity chronic venous disease. / Gloviczki, Peter; Dalsing, Michael; Henke, Peter; Lal, Brajesh K.; O'Donnell, Thomas F.; Shortell, Cynthia K.; Huang, Ying; Markovic, Jovan; Wakefield, Thomas W.

In: Journal of Vascular Surgery: Venous and Lymphatic Disorders, Vol. 5, No. 3, 01.05.2017, p. 378-398.

Research output: Contribution to journalArticle

@article{8e2dab1f6fd242e2baa82bffabf0f9ce,
title = "Report of the Society for Vascular Surgery and the American Venous Forum on the July 20, 2016 meeting of the Medicare Evidence Development and Coverage Advisory Committee panel on lower extremity chronic venous disease",
abstract = "On July 20, 2016, a Medicare Evidence Development and Coverage Advisory Committee panel assessed the benefits and risks of currently used lower extremity chronic venous disease (CVD) treatments and their effects on health outcome of the American adult population. The main purpose of the meeting was to advise the Centers for Medicare & Medicaid Services on coverage determination for interventions used for treatment of CVD. A systematic review of the Agency for Healthcare Research and Quality was presented, followed by lectures of invited experts and a public hearing of representatives of professional societies and the industry. After discussing critical issues, the panel voted for key questions. This report summarizes the presented evidence to support recommendations of the Society for Vascular Surgery/American Venous Forum coalition and the presentations on selected discussion topics. These included important venous disease evidence gaps that have not been sufficiently addressed, venous disease treatment disparities and how they may affect the health outcomes of Medicare beneficiaries, and mechanisms that might be supported by the Centers for Medicare & Medicaid Services to improve the evidence base to optimize the care of patients with lower extremity CVD.[Table presented]",
author = "Peter Gloviczki and Michael Dalsing and Peter Henke and Lal, {Brajesh K.} and O'Donnell, {Thomas F.} and Shortell, {Cynthia K.} and Ying Huang and Jovan Markovic and Wakefield, {Thomas W.}",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.jvsv.2017.02.001",
language = "English (US)",
volume = "5",
pages = "378--398",
journal = "Journal of Vascular Surgery: Venous and Lymphatic Disorders",
issn = "2213-333X",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Report of the Society for Vascular Surgery and the American Venous Forum on the July 20, 2016 meeting of the Medicare Evidence Development and Coverage Advisory Committee panel on lower extremity chronic venous disease

AU - Gloviczki, Peter

AU - Dalsing, Michael

AU - Henke, Peter

AU - Lal, Brajesh K.

AU - O'Donnell, Thomas F.

AU - Shortell, Cynthia K.

AU - Huang, Ying

AU - Markovic, Jovan

AU - Wakefield, Thomas W.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - On July 20, 2016, a Medicare Evidence Development and Coverage Advisory Committee panel assessed the benefits and risks of currently used lower extremity chronic venous disease (CVD) treatments and their effects on health outcome of the American adult population. The main purpose of the meeting was to advise the Centers for Medicare & Medicaid Services on coverage determination for interventions used for treatment of CVD. A systematic review of the Agency for Healthcare Research and Quality was presented, followed by lectures of invited experts and a public hearing of representatives of professional societies and the industry. After discussing critical issues, the panel voted for key questions. This report summarizes the presented evidence to support recommendations of the Society for Vascular Surgery/American Venous Forum coalition and the presentations on selected discussion topics. These included important venous disease evidence gaps that have not been sufficiently addressed, venous disease treatment disparities and how they may affect the health outcomes of Medicare beneficiaries, and mechanisms that might be supported by the Centers for Medicare & Medicaid Services to improve the evidence base to optimize the care of patients with lower extremity CVD.[Table presented]

AB - On July 20, 2016, a Medicare Evidence Development and Coverage Advisory Committee panel assessed the benefits and risks of currently used lower extremity chronic venous disease (CVD) treatments and their effects on health outcome of the American adult population. The main purpose of the meeting was to advise the Centers for Medicare & Medicaid Services on coverage determination for interventions used for treatment of CVD. A systematic review of the Agency for Healthcare Research and Quality was presented, followed by lectures of invited experts and a public hearing of representatives of professional societies and the industry. After discussing critical issues, the panel voted for key questions. This report summarizes the presented evidence to support recommendations of the Society for Vascular Surgery/American Venous Forum coalition and the presentations on selected discussion topics. These included important venous disease evidence gaps that have not been sufficiently addressed, venous disease treatment disparities and how they may affect the health outcomes of Medicare beneficiaries, and mechanisms that might be supported by the Centers for Medicare & Medicaid Services to improve the evidence base to optimize the care of patients with lower extremity CVD.[Table presented]

UR - http://www.scopus.com/inward/record.url?scp=85017543794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017543794&partnerID=8YFLogxK

U2 - 10.1016/j.jvsv.2017.02.001

DO - 10.1016/j.jvsv.2017.02.001

M3 - Article

C2 - 28411706

AN - SCOPUS:85017543794

VL - 5

SP - 378

EP - 398

JO - Journal of Vascular Surgery: Venous and Lymphatic Disorders

JF - Journal of Vascular Surgery: Venous and Lymphatic Disorders

SN - 2213-333X

IS - 3

ER -